CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies
Medicinal Research Reviews · 2026-07 · 46 (4) · 989-1004
DOI: 10.1002/med.70046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 31.03.2026. Verfasst von Steven He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute, Minderoo Children's Comprehensive Cancer Centre, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms, Genomics, Genome-Wide Association Study. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council NSW, Cancer Institute NSW, Cancer Institute NSW Research Capacity Building.
Abstract (Originalsprache)
CRISPR‐Cas9 genome‐wide screening has been instrumental towards identifying novel targets for drug discovery in cancer research. However, much of this research has centred specifically on adult cancers, with paediatric cancers being underserviced by current research and screening. With contemporary evidence increasingly highlighting the differences in biology between adult and children's cancers, more research has gradually occurred investigating dependencies and mechanisms of resistance in paediatric cancers through the use of CRISPR‐Cas9 genome‐wide screens. This review collates and summarises the experimental genome‐wide screens that have been performed specifically in paediatric cancer models, and highlights the versatility of this technology and the knowledge gained through this research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Cancer Institute, Minderoo Children's Comprehensive Cancer Centre, Sydney, NSW, Australia.
- School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.
ORCID-Profile: Steven He, Patrick Connerty
Förderung
- Cancer Council NSW
- Cancer Institute NSW
- Cancer Institute NSW Research Capacity Building
- Sydney Partnership for Health, Education, Research and Enterprise
Zitieren
APA
He, S., Connerty, P., & de Weck, A. (2026). CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies. Medicinal Research Reviews, 46(4), 989-1004. https://doi.org/10.1002/med.70046
Vancouver
He S, Connerty P, de Weck A. CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies. Medicinal Research Reviews. 2026;46(4):989-1004. doi:10.1002/med.70046
BibTeX
@article{He2026,
author = {He, Steven and Connerty, Patrick and de Weck, Antoine},
title = {CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {4},
pages = {989--1004},
doi = {10.1002/med.70046}
}
EUVIMED